Endocrinology

This episode of Nutrition411 explores how clinicians and dietitians can set realistic, emotionally informed expectations for patients using GLP-1 medications for obesity.

In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...

In this video roundtable discussion, Carol Wysham, MD, interviews Eugene E. Wright, Jr., MD, and Hope Warshaw, MMSc, RD, CDCES, BC-ADM, about the multidisciplinary approach to managing people with diabetes...

Samiya Khan, MD, examines the national impact of social isolation on diabetes prevalence and glycemic control in aging populations, presenting key findings from a cross-sectional study at ENDO 2025, July...

The team behind SMART, an AI-powered web application for diabetic retinopathy detection, discusses the development, validation, and clinical relevance of a lightweight, privacy-conscious screening model...

In this video, Risa M. Wolf, MD, speaks about her team's study that examined the use of diabetes technologies—continuous glucose monitors (CGMs) and insulin pumps—and whether that was associated with the...

In this expert conversation, David S. Cooper MD, professor of medicine and radiology at the Johns Hopkins University School of Medicine, explores how antithyroid medications, particularly methimazole,...

Laura Davisson, MD, MPH, FACP, professor of medicine, West Virginia University, discusses the rapidly evolving pharmacologic landscape for obesity management, including practical strategies for handling...

From GLP-1s to access deserts, Irl B. Hirsch, MD, MACP highlights key topics from his ACP Internal Medicine Meeting presentation on 2024's top endocrine studies and urgent care challenges.

In part 2 of this interview, Estelle Everett, MD, addresses the shortage of endocrinologists from underserved communities and highlights strategies to build a more diverse health care workforce. She also...